Search

Jean F. Voltaire

Examiner (ID: 18083, Phone: (571)272-3953 , Office: P/2466 )

Most Active Art Unit
2466
Art Unit(s)
2466, 2417
Total Applications
487
Issued Applications
381
Pending Applications
55
Abandoned Applications
68

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7801131 [patent_doc_number] => 08129402 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-06 [patent_title] => 'Screening molecules with anti-prion activity: kits, methods and screened molecules' [patent_app_type] => utility [patent_app_number] => 10/531594 [patent_app_country] => US [patent_app_date] => 2003-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 7450 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/129/08129402.pdf [firstpage_image] =>[orig_patent_app_number] => 10531594 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/531594
Screening molecules with anti-prion activity: kits, methods and screened molecules Oct 19, 2003 Issued
Array ( [id] => 7333522 [patent_doc_number] => 20040131682 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Pulsatile release histamine H2 antagonist dosage form' [patent_app_type] => new [patent_app_number] => 10/689566 [patent_app_country] => US [patent_app_date] => 2003-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4608 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20040131682.pdf [firstpage_image] =>[orig_patent_app_number] => 10689566 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/689566
Pulsatile release histamine H2 antagonist dosage form Oct 19, 2003 Abandoned
Array ( [id] => 580864 [patent_doc_number] => 07452910 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-18 [patent_title] => 'Indolyl-3-glyoxylic acid derivatives having therapeutically valuable properties' [patent_app_type] => utility [patent_app_number] => 10/686809 [patent_app_country] => US [patent_app_date] => 2003-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 3984 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/452/07452910.pdf [firstpage_image] =>[orig_patent_app_number] => 10686809 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/686809
Indolyl-3-glyoxylic acid derivatives having therapeutically valuable properties Oct 16, 2003 Issued
Array ( [id] => 4456350 [patent_doc_number] => 07893078 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-22 [patent_title] => 'Use of cyclopamine in the treatment of basal cell carcinoma and other tumors' [patent_app_type] => utility [patent_app_number] => 10/682584 [patent_app_country] => US [patent_app_date] => 2003-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 20 [patent_no_of_words] => 6682 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/893/07893078.pdf [firstpage_image] =>[orig_patent_app_number] => 10682584 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/682584
Use of cyclopamine in the treatment of basal cell carcinoma and other tumors Oct 8, 2003 Issued
Array ( [id] => 224984 [patent_doc_number] => 07605167 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-20 [patent_title] => 'Use of cyclopamine in the treatment of psoriasis' [patent_app_type] => utility [patent_app_number] => 10/682662 [patent_app_country] => US [patent_app_date] => 2003-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 52 [patent_no_of_words] => 9296 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/605/07605167.pdf [firstpage_image] =>[orig_patent_app_number] => 10682662 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/682662
Use of cyclopamine in the treatment of psoriasis Oct 8, 2003 Issued
Array ( [id] => 4456350 [patent_doc_number] => 07893078 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-22 [patent_title] => 'Use of cyclopamine in the treatment of basal cell carcinoma and other tumors' [patent_app_type] => utility [patent_app_number] => 10/682584 [patent_app_country] => US [patent_app_date] => 2003-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 20 [patent_no_of_words] => 6682 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/893/07893078.pdf [firstpage_image] =>[orig_patent_app_number] => 10682584 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/682584
Use of cyclopamine in the treatment of basal cell carcinoma and other tumors Oct 8, 2003 Issued
Array ( [id] => 7469312 [patent_doc_number] => 20040167212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-26 [patent_title] => 'X-nitro compounds, pharmaceutical compositions thereof and uses thereof' [patent_app_type] => new [patent_app_number] => 10/681855 [patent_app_country] => US [patent_app_date] => 2003-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8495 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20040167212.pdf [firstpage_image] =>[orig_patent_app_number] => 10681855 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/681855
X-nitro compounds, pharmaceutical compositions thereof and uses thereof Oct 6, 2003 Abandoned
Array ( [id] => 7169700 [patent_doc_number] => 20040077686 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'Inhibition of cyclooxygenase-2 activity' [patent_app_type] => new [patent_app_number] => 10/680606 [patent_app_country] => US [patent_app_date] => 2003-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2360 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20040077686.pdf [firstpage_image] =>[orig_patent_app_number] => 10680606 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/680606
Inhibition of cyclooxygenase-2 activity Oct 6, 2003 Abandoned
Array ( [id] => 5656535 [patent_doc_number] => 20060142271 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Novel lapacho compounds and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 10/528295 [patent_app_country] => US [patent_app_date] => 2003-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9226 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20060142271.pdf [firstpage_image] =>[orig_patent_app_number] => 10528295 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/528295
Novel lapacho compounds and methods of use thereof Sep 16, 2003 Abandoned
Array ( [id] => 7674595 [patent_doc_number] => 20040127523 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Methods of treating cancer with HDAC inhibitors' [patent_app_type] => new [patent_app_number] => 10/665079 [patent_app_country] => US [patent_app_date] => 2003-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 24543 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20040127523.pdf [firstpage_image] =>[orig_patent_app_number] => 10665079 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/665079
Methods of treating cancer with HDAC inhibitors Sep 15, 2003 Abandoned
Array ( [id] => 7270411 [patent_doc_number] => 20040058929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-25 [patent_title] => 'Unit dosage form' [patent_app_type] => new [patent_app_number] => 10/661951 [patent_app_country] => US [patent_app_date] => 2003-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7276 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20040058929.pdf [firstpage_image] =>[orig_patent_app_number] => 10661951 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/661951
Unit dosage form Sep 11, 2003 Abandoned
Array ( [id] => 7207284 [patent_doc_number] => 20040087579 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Enhancement of effectiveness of 5-fluorouracil in treatment of tumor metastases and cancer' [patent_app_type] => new [patent_app_number] => 10/660798 [patent_app_country] => US [patent_app_date] => 2003-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1353 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20040087579.pdf [firstpage_image] =>[orig_patent_app_number] => 10660798 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/660798
Enhancement of effectiveness of 5-fluorouracil in treatment of tumor metastases and cancer Sep 11, 2003 Issued
Array ( [id] => 7255798 [patent_doc_number] => 20050075396 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-07 [patent_title] => 'Use of (-)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of insulin resistance, Type 2 diabetes and hyperlipidemia' [patent_app_type] => utility [patent_app_number] => 10/660112 [patent_app_country] => US [patent_app_date] => 2003-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 16550 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20050075396.pdf [firstpage_image] =>[orig_patent_app_number] => 10660112 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/660112
Use of (-)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of insulin resistance, Type 2 diabetes and hyperlipidemia Sep 9, 2003 Abandoned
Array ( [id] => 7169522 [patent_doc_number] => 20040077660 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'Method for treating insulin resistance, abdominal obesity, hypertension, hyperinsulinemia, and elevated blood lipids with a cortisol inhibitor' [patent_app_type] => new [patent_app_number] => 10/654809 [patent_app_country] => US [patent_app_date] => 2003-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1448 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20040077660.pdf [firstpage_image] =>[orig_patent_app_number] => 10654809 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/654809
Method for treating insulin resistance, abdominal obesity, hypertension, hyperinsulinemia, and elevated blood lipids with a cortisol inhibitor Sep 3, 2003 Issued
Array ( [id] => 7674648 [patent_doc_number] => 20040127470 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Methods and compositions for the prevention or treatment of neoplasia comprising a Cox-2 inhibitor in combination with an epidermal growth factor receptor antagonist' [patent_app_type] => new [patent_app_number] => 10/651916 [patent_app_country] => US [patent_app_date] => 2003-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60266 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20040127470.pdf [firstpage_image] =>[orig_patent_app_number] => 10651916 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/651916
Methods and compositions for the prevention or treatment of neoplasia comprising a Cox-2 inhibitor in combination with an epidermal growth factor receptor antagonist Aug 28, 2003 Abandoned
Array ( [id] => 7256095 [patent_doc_number] => 20040259811 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-23 [patent_title] => 'Chemotherapy method using x-rays' [patent_app_type] => new [patent_app_number] => 10/651307 [patent_app_country] => US [patent_app_date] => 2003-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6985 [patent_no_of_claims] => 121 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20040259811.pdf [firstpage_image] =>[orig_patent_app_number] => 10651307 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/651307
Chemotherapy method using x-rays Aug 27, 2003 Issued
Array ( [id] => 7389744 [patent_doc_number] => 20040037800 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'Process for treating animal habitats' [patent_app_type] => new [patent_app_number] => 10/648993 [patent_app_country] => US [patent_app_date] => 2003-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3335 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20040037800.pdf [firstpage_image] =>[orig_patent_app_number] => 10648993 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/648993
Process for treating animal habitats Aug 26, 2003 Issued
Array ( [id] => 7398663 [patent_doc_number] => 20040039048 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'Therapy with cannabinoid compounds for the treatment of brain tumors' [patent_app_type] => new [patent_app_number] => 10/647739 [patent_app_country] => US [patent_app_date] => 2003-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3881 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20040039048.pdf [firstpage_image] =>[orig_patent_app_number] => 10647739 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/647739
Therapy with cannabinoid compounds for the treatment of brain tumors Aug 24, 2003 Abandoned
Array ( [id] => 7207639 [patent_doc_number] => 20050043380 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Composition for treatment of malignant tumors' [patent_app_type] => utility [patent_app_number] => 10/642549 [patent_app_country] => US [patent_app_date] => 2003-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 413 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20050043380.pdf [firstpage_image] =>[orig_patent_app_number] => 10642549 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/642549
Composition for treatment of malignant tumors Aug 17, 2003 Abandoned
Array ( [id] => 7127834 [patent_doc_number] => 20050059578 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Compositions comprising phosphatidylethanolamine-binding peptides linked to anti-viral agents' [patent_app_type] => utility [patent_app_number] => 10/642121 [patent_app_country] => US [patent_app_date] => 2003-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 53 [patent_no_of_words] => 118989 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20050059578.pdf [firstpage_image] =>[orig_patent_app_number] => 10642121 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/642121
Compositions comprising phosphatidylethanolamine-binding peptides linked to anti-viral agents Aug 14, 2003 Issued
Menu